These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1329295)

  • 1. The genetic basis of malignant hyperthermia.
    MacLennan DH
    Trends Pharmacol Sci; 1992 Aug; 13(8):330-4. PubMed ID: 1329295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hyperthermia.
    MacLennan DH; Phillips MS
    Science; 1992 May; 256(5058):789-94. PubMed ID: 1589759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic basis of malignant hyperthermia.
    Moochhala SM; Tan WT; Lee TL
    Ann Acad Med Singap; 1994 Jul; 23(4):475-8. PubMed ID: 7979121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia.
    Fujii J; Otsu K; Zorzato F; de Leon S; Khanna VK; Weiler JE; O'Brien PJ; MacLennan DH
    Science; 1991 Jul; 253(5018):448-51. PubMed ID: 1862346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The point mutation Arg615-->Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia.
    Otsu K; Nishida K; Kimura Y; Kuzuya T; Hori M; Kamada T; Tada M
    J Biol Chem; 1994 Apr; 269(13):9413-5. PubMed ID: 7511586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the skeletal muscle ryanodine receptor gene in malignant hyperthermia.
    MacLennan DH; Otsu K; Fujii J; Zorzato F; Phillips MS; O'Brien PJ; Archibald AL; Britt BA; Gillard EF; Worton RG
    Symp Soc Exp Biol; 1992; 46():189-201. PubMed ID: 1341035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional correlates of a mutation in the malignant hyperthermia-susceptible pig ryanodine receptor.
    Mickelson JR; Knudson CM; Kennedy CF; Yang DI; Litterer LA; Rempel WE; Campbell KP; Louis CF
    FEBS Lett; 1992 Apr; 301(1):49-52. PubMed ID: 1333412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic organization and analysis of the 5' end of the porcine ryanodine receptor gene (ryr1).
    Brenig B; Brem G
    FEBS Lett; 1992 Feb; 298(2-3):277-9. PubMed ID: 1312025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca2+ release channels of pigs heterozygous for malignant hyperthermia.
    Shomer NH; Mickelson JR; Louis CF
    Muscle Nerve; 1995 Oct; 18(10):1167-76. PubMed ID: 7659111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation and inhibition of [3H]ryanodine binding to sarcoplasmic reticulum from malignant hyperthermia susceptible pigs.
    Mickelson JR; Litterer LA; Jacobson BA; Louis CF
    Arch Biochem Biophys; 1990 Apr; 278(1):251-7. PubMed ID: 2321964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cosegregation of porcine malignant hyperthermia and a probable causal mutation in the skeletal muscle ryanodine receptor gene in backcross families.
    Otsu K; Khanna VK; Archibald AL; MacLennan DH
    Genomics; 1991 Nov; 11(3):744-50. PubMed ID: 1774073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia.
    Gillard EF; Otsu K; Fujii J; Duff C; de Leon S; Khanna VK; Britt BA; Worton RG; MacLennan DH
    Genomics; 1992 Aug; 13(4):1247-54. PubMed ID: 1354642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct immunopeptide maps of the sarcoplasmic reticulum Ca2+ release channel in malignant hyperthermia.
    Knudson CM; Mickelson JR; Louis CF; Campbell KP
    J Biol Chem; 1990 Feb; 265(5):2421-4. PubMed ID: 2154446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
    Du GG; Oyamada H; Khanna VK; MacLennan DH
    Biochem J; 2001 Nov; 360(Pt 1):97-105. PubMed ID: 11695996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cysteine-for-arginine substitution (R614C) in the human skeletal muscle calcium release channel cosegregates with malignant hyperthermia.
    Hogan K; Couch F; Powers PA; Gregg RG
    Anesth Analg; 1992 Sep; 75(3):441-8. PubMed ID: 1510267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-segregation of the malignant hyperthermia and the Arg615-Cys615 mutation in the skeletal muscle calcium release channel protein in five European Landrace and Pietrain pig breeds.
    Vögeli P; Bolt R; Fries R; Stranzinger G
    Anim Genet; 1994 Jun; 25 Suppl 1():59-66. PubMed ID: 7943985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the calcium release channel of skeletal muscle sarcoplasmic reticulum in malignant hyperthermia.
    MacLennan DH; Chen SR
    Ann N Y Acad Sci; 1993 Dec; 707():294-304. PubMed ID: 9137560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic organization of the porcine skeletal muscle ryanodine receptor (RYR1) gene coding region 4624 to 7929.
    Leeb T; Schmölzl S; Brem G; Brenig B
    Genomics; 1993 Nov; 18(2):349-54. PubMed ID: 8288238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia may be due to a defect in a large Ca2+ release channel protein.
    Davies K
    Trends Genet; 1990 Jun; 6(6):171-2. PubMed ID: 2164719
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
    Laver DR; Owen VJ; Junankar PR; Taske NL; Dulhunty AF; Lamb GD
    Biophys J; 1997 Oct; 73(4):1913-24. PubMed ID: 9336187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.